BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31473848)

  • 1. Current Development of Monoclonal Antibodies in Cancer Therapy.
    Parakh S; King D; Gan HK; Scott AM
    Recent Results Cancer Res; 2020; 214():1-70. PubMed ID: 31473848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated delivery of therapeutics for cancer therapy.
    Parakh S; Parslow AC; Gan HK; Scott AM
    Expert Opin Drug Deliv; 2016; 13(3):401-19. PubMed ID: 26654403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
    Philips GK; Atkins M
    Int Immunol; 2015 Jan; 27(1):39-46. PubMed ID: 25323844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-based therapeutics in oncology.
    Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy.
    O'Mahony D; Bishop MR
    Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-specific antibodies for cancer immunotherapy.
    Jachimowicz RD; Borchmann S; Rothe A
    BioDrugs; 2014 Aug; 28(4):331-43. PubMed ID: 24638872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors.
    Di Fede G; Bronte G; Rizzo S; Rolfo Cervetto C; Cocorullo G; Gulotta G; Bazan V; Russo A
    Expert Opin Biol Ther; 2011 Nov; 11(11):1433-45. PubMed ID: 21663530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors.
    Chester C; Marabelle A; Houot R; Kohrt HE
    Curr Opin Immunol; 2015 Apr; 33():1-8. PubMed ID: 25576932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in immunotherapy and monoclonal antibody treatment of cancer.
    Cheng JD; Rieger PT; von Mehren M; Adams GP; Weiner LM
    Semin Oncol Nurs; 2000 Nov; 16(4 Suppl 1):2-12. PubMed ID: 11151455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP
    Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Immunotherapy: The Dawn of Antibody Cocktails.
    Marrocco I; Romaniello D; Yarden Y
    Methods Mol Biol; 2019; 1904():11-51. PubMed ID: 30539465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in monoclonal antibody-based immunotherapy for cancer treatment].
    Guo Y
    Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):857-70. PubMed ID: 26672362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in research on monoclonal antibody agents for cancer therapy].
    Zhen Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):9-13. PubMed ID: 12903485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-targeted immunotherapy for treatment of malignancy.
    White CA; Weaver RL; Grillo-López AJ
    Annu Rev Med; 2001; 52():125-45. PubMed ID: 11160771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types.
    Ascierto PA; Kalos M; Schaer DA; Callahan MK; Wolchok JD
    Clin Cancer Res; 2013 Mar; 19(5):1009-20. PubMed ID: 23460532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.